Tailored for: Researcher · General research answer

Bottom line. Current evidence suggests that RNA chemical modifications, most prominently $N^{6}$ -methyladenosine, encode a dynamic and reversible layer of post-transcriptional gene regulation termed the epitranscriptome.

Direct Answer

Mechanism: Direct

3 studies

Rigor: 1/10

Current evidence suggests that RNA chemical modifications, primarily $N^{6}$ -methyladenosine ( $m^{6} A$ ), encode a significant and reversible post-transcriptional layer of gene regulation termed the 'epitranscriptome' Synthesized23. This regulatory layer is maintained by a complex machinery of molecular 'writers' (methyltransferases), 'erasers' (demethylases), and 'readers' (binding proteins) that dictate the installation, removal, and functional interpretation of these marks to dynamically alter RNA fate 1.

Literature Landscape

5 studies

Rigor: 4/11

The study of the epitranscriptome has evolved through several phases, with a central cluster focused on mRNA $m^{6} A$ modification and another on the biochemical metabolism of adenosine methylation. Anchor studies have characterized the core methyltransferase complex 4 and the global topology of the human and mouse methylomes 5. Emerging research bridges these foundational mechanisms with dynamic cellular responses, such as the heat shock response 6 and the translation of circular RNAs 7. Recent work has shifted toward integrating these mechanisms with epigenetic markers to coordinate gene expression 8.

Biochemical Mechanism of Modification and Recognition

Mechanism: Proximal

6 studies

Rigor: 1/10

The core $m^{6} A$ 'writer' is a heterodimer composed of METTL3 and METTL14 9. METTL3 acts as the catalytic subunit, while METTL14 is essential for substrate recognition and maintaining complex integrity; their activity is further regulated by WTAP, which is required for their localization to nuclear speckles Synthesized113. Reversibility is conferred by 'erasers' such as FTO and ALKBH5, which convert $m^{6} A$ back to adenosine 10. Functional outcomes are determined by 'readers' like the YTH domain family (YTHDF1-3, YTHDC1-2), which utilize a conserved hydrophobic aromatic cage to recognize $m^{6} A$ 11. Additionally, IGF2BP proteins (1, 2, and 3) recognize the GG( $m^{6} A$ )C sequence through their KH domains to enhance mRNA stability 12.

Regulation of RNA Metabolism and Stability

Mechanism: Proximal

5 studies

Rigor: 6/11

RNA modifications influence every stage of the RNA life cycle. Stability is often negatively regulated by YTHDF2, which recruits the CCR4-NOT deadenylase complex through a direct interaction with the CNOT1 subunit to initiate $m^{6} A$ -containing RNA decay 14. In contrast, YTHDF1 promotes translation efficiency by interacting with initiation factors like eIF3 15. Nuclear processing is also affected; YTHDC1 facilitates the nuclear export of methylated mRNAs by interacting with the export adaptor SRSF3 16. Beyond linear mRNA, $m^{6} A$ consensus motifs are enriched in circular RNAs (circRNAs), where a single $m^{6} A$ site can drive cap-independent translation requiring eIF4G2 and YTHDF3 7. Furthermore, ' $m^{6} A$ -switches' can remodel RNA secondary structure, such as exposing single-stranded U-tracts to enhance the binding of hnRNPC, thereby regulating alternative splicing 17.

Developmental and Clinical Significance

Mechanism: Direct

4 studies

Rigor: 4/11

The epitranscriptome is critical for cell fate transitions. In embryonic stem cells (ESCs), $m^{6} A$ facilitates the timely degradation of pluripotency transcripts like Nanog and Klf4, enabling the transition to differentiation 18. In the adult brain, neuronal $m^{6} A / m$ levels are dynamically regulated by acute stress, with region-specific changes in Fto and Alkbh5 expression 19. Dysregulation is linked to diverse pathologies: METTL3 overexpression in hepatocellular carcinoma promotes progression by enhancing YTHDF2-mediated degradation of the tumor suppressor SOCS2 20. In endometrial cancer, METTL14 mutations or reduced METTL3 levels activate AKT signaling, leading to increased proliferation and tumorigenicity 21.

Contradictions and Open Questions

The role of $m^{6} A$ in splicing remains a point of debate in the literature. While some evidence indicates that FTO regulates alternative splicing by targeting pre-mRNAs in intronic regions 22 and $m^{6} A$ -switches regulate splicing via hnRNPC 17, other studies suggest $m^{6} A$ is primarily associated with cytoplasmic turnover rather than being a core requirement for splicing 23. Additionally, while most $m^{6} A$ reader functions in the cytoplasm are categorized into distinct pathways (e.g., YTHDF1 for translation, YTHDF2 for decay), YTHDF3 has been reported to facilitate both translation and decay, suggesting potential synergy or competition that is not fully understood 24.

Evidence Gaps and Limitations

4 studies

Rigor: 1/10

Current mapping technologies, such as MeRIP-seq and $m^{6} A$ -seq, often lack single-molecule resolution and fail to provide absolute stoichiometry for modifications at specific sites 3. While third-generation sequencing like Oxford Nanopore (ONT) shows promise in detecting $m^{6} A$ through base-calling 'errors' with ~90% accuracy, these methods currently rely on information from all reads mapping to a site rather than identifying modifications on individual molecules 25. Furthermore, while $m^{6} A$ is well-characterized, the prevalence and physiological roles of other modifications like $m^{5} C$ and $N^{1}$ -methyladenosine ( $m^{1} A$ ) in mRNA remain largely uncharted Synthesized2627.

Trust Index

Trusted

More trust signals

Solid signal.Good confidence.

Holds up across most trust checks. A few facets are worth a closer look before you cite it.

Grounding

Claims match their citations

71 / 100

Caution

Checks that each cited claim is backed by the paper's full text, not just its abstract. Supports that fail this check are removed from the brief before you see it.

15 of 21 cited supports verified against full text

1 cited support(s) removed after failing verification

5 cited support(s) not verified against full text

Provenance

Credible, traceable sources

90 / 100

Evidence strength

Quality of the underlying studies

41 / 100

Caution

Reproducibility

Replicated across independent studies

75 / 100

Durability

Holds up against newer evidence

65 / 100

Caution

Reagent validity

Cell-line & antibody validity

80 / 100

Partial

Caution

Sub-question coverage

Each part of your question, and how thoroughly the evidence answered it.

What are the most prevalent and biologically significant RNA chemical modifications (e.g., m6A, m5C, pseudouridine)?

Covered

2/3 citation-checked

3 studies

How do RNA chemical modifications regulate RNA metabolism, including stability, splicing, and translation?

Covered

Citations checked

Mechanism: Proximal

4 studies · 1 proximal, 3 unclassified

What are the molecular 'writers', 'erasers', and 'readers' that orchestrate the RNA modification landscape?

Covered

Citations checked

Mechanism: Direct

4 studies · 1 direct, 3 unclassified

How do RNA modifications contribute to cellular differentiation and developmental processes?

Covered

1/3 citation-checked

3 studies

What evidence exists for the reversible and dynamic nature of RNA modifications in response to environmental stimuli?

Covered

2/3 citation-checked

3 studies

What are the implications of dysregulated RNA modifications in human diseases, particularly cancer and neurological disorders?

Covered

2/3 citation-checked

Mechanism: Direct

3 studies · 1 direct, 1 proximal, 1 distal

2 statements removed during verification (not confirmed by the cited source)

PubMed 29547716
This paper focuses on the Zc3h13 complex and m6A but does not discuss coordination with epigenetic markers like histone modifications.
Solution structure of the YTH domain in complex with N6-methyladenosine RNA: a reader of methylated RNA
The specific entity YTHDC2 is not mentioned in the paper.

Check this brief

Add to Evidence Watch